Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Williamson C, Moodley C, Magaret CA, Giorgi EE, Rolland M, Westfall DH, Yssel A, Deng W, Rossenkhan R, Mkhize NN, Chen L, Zhao H, Bhattacharya T, Pankow A, Murrell B, York T, Gwashu-Nyangiwe A, Ndabambi N, Thebus R, Cohen P, Lambson B, Kaldine H, Bhebhe S, Juraska M, Bai H, deCamp AC, Miner MD, Ludwig J, Molitor C, Beaume N, Matten D, Huang Y, Zhang L, Reeves DB, Mayer B, Karuna ST, Hural JA, Morris L, Montefiori D, Bumgarner RE, Moore PL, Edlefsen PT, Edupuganti S, Mgodi N, McElrath MJ, Cohen MS, Corey L, Gilbert PB, Mullins JI

Open source

DOI
10.1038/s41467-026-70888-0
Published
2026 Apr 3
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-70888-0,
  title = {Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.},
  author = {Williamson C and Moodley C and Magaret CA and Giorgi EE and Rolland M and Westfall DH and Yssel A and Deng W and Rossenkhan R and Mkhize NN and Chen L and Zhao H and Bhattacharya T and Pankow A and Murrell B and York T and Gwashu-Nyangiwe A and Ndabambi N and Thebus R and Cohen P and Lambson B and Kaldine H and Bhebhe S and Juraska M and Bai H and deCamp AC and Miner MD and Ludwig J and Molitor C and Beaume N and Matten D and Huang Y and Zhang L and Reeves DB and Mayer B and Karuna ST and Hural JA and Morris L and Montefiori D and Bumgarner RE and Moore PL and Edlefsen PT and Edupuganti S and Mgodi N and McElrath MJ and Cohen MS and Corey L and Gilbert PB and Mullins JI},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-70888-0},
  url = {https://doi.org/10.1038/s41467-026-70888-0}
}

RIS

TY  - JOUR
TI  - Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
AU  - Williamson C
AU  - Moodley C
AU  - Magaret CA
AU  - Giorgi EE
AU  - Rolland M
AU  - Westfall DH
AU  - Yssel A
AU  - Deng W
AU  - Rossenkhan R
AU  - Mkhize NN
AU  - Chen L
AU  - Zhao H
AU  - Bhattacharya T
AU  - Pankow A
AU  - Murrell B
AU  - York T
AU  - Gwashu-Nyangiwe A
AU  - Ndabambi N
AU  - Thebus R
AU  - Cohen P
AU  - Lambson B
AU  - Kaldine H
AU  - Bhebhe S
AU  - Juraska M
AU  - Bai H
AU  - deCamp AC
AU  - Miner MD
AU  - Ludwig J
AU  - Molitor C
AU  - Beaume N
AU  - Matten D
AU  - Huang Y
AU  - Zhang L
AU  - Reeves DB
AU  - Mayer B
AU  - Karuna ST
AU  - Hural JA
AU  - Morris L
AU  - Montefiori D
AU  - Bumgarner RE
AU  - Moore PL
AU  - Edlefsen PT
AU  - Edupuganti S
AU  - Mgodi N
AU  - McElrath MJ
AU  - Cohen MS
AU  - Corey L
AU  - Gilbert PB
AU  - Mullins JI
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-70888-0
UR  - https://doi.org/10.1038/s41467-026-70888-0
ER  -

APA

C, W., C, M., CA, M., EE, G., M, R., DH, W., A, Y., W, D., R, R., NN, M., L, C., H, Z., T, B., A, P., B, M., T, Y., A, G., N, N., R, T., P, C., B, L., H, K., S, B., M, J., H, B., AC, D., MD, M., J, L., C, M., N, B., D, M., Y, H., L, Z., DB, R., B, M., ST, K., JA, H., L, M., D, M., RE, B., PL, M., PT, E., S, E., N, M., MJ, M., MS, C., L, C., PB, G., & JI, M. (2026). Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.. Nature communications. https://doi.org/10.1038/s41467-026-70888-0

Source records